Literature DB >> 21356283

Chitosan-g-poly(N-isopropylacrylamide) based nanogels for tumor extracellular targeting.

Cunxian Duan1, Dianrui Zhang, Feihu Wang, Dandan Zheng, Lejiao Jia, Feifei Feng, Yue Liu, Yancai Wang, Keli Tian, Fengshan Wang, Qiang Zhang.   

Abstract

The principle objective of this research was to develop and characterize pH-responsive and biocompatible nanogels as a tumor-targeting drug delivery system. The nanogels were self-assembled from chitosan-based copolymers, chitosan-graft-poly(N-isopropylacrylamide) (CS-g-PNIPAm). The copolymers were synthesized via free radical copolymerization and characterized for their chemical structure by FT-IR and (1)H NMR. These copolymers could be efficiently loaded with oridonin (ORI) and the characteristics of ORI-loaded nanogels were evaluated. Drug release researches indicated that the ORI-loaded nanogels displayed pH-dependent release behaviors. Based on MTT assay and cellular morphological analysis, the anti-tumor activity of ORI-loaded nanogels was higher at pH 6.5 than at pH 7.4. In conclusion, the obtained nanogels appeared to be of great promise in tumor extracellular pH targeting for ORI.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21356283     DOI: 10.1016/j.ijpharm.2011.02.050

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  Promoting antitumor activities of hydroxycamptothecin by encapsulation into acid-labile nanoparticles using electrospraying.

Authors:  Xiaoming Luo; Guoqing Jia; Haixing Song; Chaoyu Liu; Guannan Wu; Xiaohong Li
Journal:  Pharm Res       Date:  2013-07-25       Impact factor: 4.200

2.  Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin.

Authors:  Zhonggen Shi; Rui Guo; Weichang Li; Yi Zhang; Wei Xue; Yu Tang; Yuanming Zhang
Journal:  J Mater Sci Mater Med       Date:  2013-12-11       Impact factor: 3.896

3.  Characterization of injectable hydrogels based on poly(N-isopropylacrylamide)-g-chondroitin sulfate with adhesive properties for nucleus pulposus tissue engineering.

Authors:  Craig Wiltsey; Pamela Kubinski; Thomas Christiani; Katelynn Toomer; Joseph Sheehan; Amanda Branda; Jennifer Kadlowec; Cristina Iftode; Jennifer Vernengo
Journal:  J Mater Sci Mater Med       Date:  2013-01-31       Impact factor: 3.896

Review 4.  Therapeutic nanomedicine for brain cancer.

Authors:  Stephany Y Tzeng; Jordan J Green
Journal:  Ther Deliv       Date:  2013-06

Review 5.  Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art.

Authors:  Govind Soni; Khushwant S Yadav
Journal:  Saudi Pharm J       Date:  2014-04-16       Impact factor: 4.330

6.  Dual-Drug Containing Core-Shell Nanoparticles for Lung Cancer Therapy.

Authors:  Jyothi U Menon; Aneetta Kuriakose; Roshni Iyer; Elizabeth Hernandez; Leah Gandee; Shanrong Zhang; Masaya Takahashi; Zhang Zhang; Debabrata Saha; Kytai T Nguyen
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

7.  Controlled drug delivery vehicles for cancer treatment and their performance.

Authors:  Sudipta Senapati; Arun Kumar Mahanta; Sunil Kumar; Pralay Maiti
Journal:  Signal Transduct Target Ther       Date:  2018-03-16

8.  l-Peptide functionalized dual-responsive nanoparticles for controlled paclitaxel release and enhanced apoptosis in breast cancer cells.

Authors:  Shiwei Niu; David H Bremner; Junzi Wu; Jianrong Wu; Haijun Wang; Heyu Li; Qianqian Qian; Hong Zheng; Limin Zhu
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

9.  Gemcitabine hydrochloride-loaded functionalised carbon nanotubes as potential carriers for tumour targeting.

Authors:  Shilpee Das; Jagruti L Desai; Hetal P Thakkar
Journal:  Indian J Pharm Sci       Date:  2013-11       Impact factor: 0.975

Review 10.  Solubility and Bioavailability Enhancement of Oridonin: A Review.

Authors:  Yuanyuan Zhang; Shaohua Wang; Mengmeng Dai; Jijuan Nai; Liqiao Zhu; Huagang Sheng
Journal:  Molecules       Date:  2020-01-14       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.